Authors: F. Tardif, A. Guiot, L. Golanski
Affilation: CEA-Liten, France
Pages: 98 - 101
A strong release limitation of single nanoparticles from the commercial manufactured “nanoproducts” is absolutely necessary to protect the consumers and represents also a pragmatic way to facilitate acceptance for nanomaterial commercialization before obtaining definitive toxicological results.
Nanotech Conference Proceedings are now published in the TechConnect Briefs